Agusti Alentorn Selected Research

Glioma (Gliomas)

1/2023	Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
1/2021	Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis.
11/2020	Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions.
1/2020	Mechanisms and therapeutic implications of hypermutation in gliomas.
12/2019	CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
6/2017	Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model.
9/2015	CIC inactivating mutations identify aggressive subset of 1p19q codeleted gliomas.
9/2014	Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Agusti Alentorn Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 05/2014
8	Glioma (Gliomas) 01/2023 - 09/2014
7	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 05/2013
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2023 - 05/2020
4	Cerebellar Ataxia (Dysmetria) 01/2023 - 05/2020
4	Lymphoma (Lymphomas) 01/2022 - 01/2017
3	Oligodendroglioma 12/2019 - 01/2016
2	Autoimmune Diseases of the Nervous System 11/2023 - 02/2023
2	Brain Neoplasms (Brain Tumor) 05/2023 - 01/2023
2	Inflammation (Inflammations) 01/2022 - 12/2020
2	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2021 - 05/2020
2	Carcinogenesis 01/2019 - 12/2018
2	Astrocytoma (Pilocytic Astrocytoma) 01/2016 - 01/2015
1	Sleepiness 11/2023
1	Sleep Wake Disorders 11/2023
1	Disorders of Excessive Somnolence (Hypersomnia) 11/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2023
1	Encephalomyelitis (Myeloencephalitis) 01/2023
1	Autoimmune limbic encephalitis 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023
1	Encephalitis (Encephalitis, Rasmussen) 01/2023
1	Ataxia (Dyssynergia) 01/2022
1	Infections 09/2021
1	COVID-19 09/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2020
1	Turcot syndrome 01/2020
1	Necrosis 12/2019
1	Central Nervous System Neoplasms 12/2019
1	Aseptic Meningitis 01/2019
1	Diffuse Intrinsic Pontine Glioma 10/2018
1	Hemangiopericytoma 09/2018
1	Solitary Fibrous Tumors 09/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Paraneoplastic Cerebellar Degeneration 01/2018
1	Hypoxia (Hypoxemia) 01/2016
1	Lung Neoplasms (Lung Cancer) 11/2015
1	Melanoma (Melanoma, Malignant) 11/2015
1	Circulating Neoplastic Cells 01/2015

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2015
5	AntibodiesIBA 01/2023 - 05/2020
4	Biomarkers (Surrogate Marker)IBA 12/2017 - 05/2014
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 11/2023 - 01/2021
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 12/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 06/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2018 - 05/2013
2	Vincristine (Oncovin)FDA LinkGeneric 06/2017 - 01/2015
2	Procarbazine (Matulane)FDA Link 06/2017 - 01/2015
2	Lomustine (CCNU)FDA Link 06/2017 - 01/2015
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 11/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2023
1	mesoglycanIBA 01/2023
1	Immune Checkpoint ProteinsIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	IronIBA 09/2021
1	ferrocifenIBA 09/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	HLA-DRB1*07 antigenIBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	hemoglobin ASIBA 01/2019
1	ChromatinIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	MicroRNAs (MicroRNA)IBA 12/2018
1	dipinacoline glutamateIBA 10/2018
1	pazopanib FDA Link 09/2018
1	anti-Yo autoantibodiesIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	CytokinesIBA 12/2017
1	P-2 (P 2)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	VemurafenibIBA 01/2015
1	Everolimus FDA Link 01/2015
1	Nucleic AcidsIBA 01/2015
1	Complement System Proteins (Complement)IBA 09/2014
1	Formaldehyde (Formol)FDA Link 09/2014
1	ParaffinIBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Therapeutics 01/2023 - 01/2015
3	Radiotherapy 05/2023 - 11/2015
2	Precision Medicine 12/2018 - 11/2015
1	Artificial Respiration (Mechanical Ventilation) 09/2021
1	Aftercare (After-Treatment) 01/2020
1	Biological Therapy 12/2017
1	Molecular Targeted Therapy 11/2015